Assessment of liver fibrosis can be challenging after cure of hepatitis C virus (HCV) because many noninvasive markers of liver fibrosis incorporate tests of liver inflammation, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT). This evidence concerns the gene GPT and Hepatic fibrosis.